Cys-LC-LL-37 is a cysteine-modified variant of the human cathelicidin peptide LL-37, used to investigate redox-sensitive structural changes. Its amphipathic architecture supports studies of membrane interaction and peptide-lipid assembly. Researchers examine its conformational dynamics to understand innate immune peptide function. The molecule also aids analysis of disulfide-dependent modulation.
CAT No: L07004
1. Cationic cell-penetrating peptides are potent furin inhibitors
4. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More